Delivery Order SPE2DR25D2006-SPE2DR26F57DK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,701.90 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside contract with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent organization, Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Arimidex 1 mg tablets (30-count packages) with a ceiling value of $7,580.16. This non-set-aside, firm fixed-price delivery order is scheduled for completion by January 7, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $7,213.21 delivery order contract to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 12, 2025, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a quantity of 30 units, valued at $3,974.03. The contract, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract valued at $5,685.12. The award was made on January 2, 2026, with an ultimate completion date of January 5, 2026, and represents a competitively awarded, non-set-aside transaction. AmerisourceBergen will perform this contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,034.37 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price contract represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,790.08 to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by January 7, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $15,357.37 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed-price contract valued at $49,344.60, with an ultimate completion date of January 5, 2026. This competitive award, issued on January 2, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 units) under a firm fixed-price contract valued at $49,291.72. The order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57DKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $82,443.45 to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 7, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The contractor's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Arimidex, an aromatase inhibitor used in oncology treatment, reflects the company's role in supplying essential pharmaceutical commodities to support military treatment facilities and federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.4k | 1/5/26 |